Study of triglyceride changes during pregnancy and neonatal birth weight and adverse outcomes

Abstract

AbstractBackgroundChanges of maternal triglyceride concentrations are closely associated with intrauterine fetal growth and development, but the effect of mid‐ to late‐term triglyceride changes on birth weight is uncertain. This study investigated the association between changes in triglycerides in mid to late in pregnant women gestational age ≥ 35 weeks on neonatal birth weight and adverse outcomes.MethodsThis cohort study was based on 931 pregnant women with a singleton delivery at gestational age ≥ 35 weeks from January 1, 2022 to December 31, 2022 at Nanjing Lishui People's Hospital (NJLSPH) in China, with all maternal triglyceride concentrations measured at mid‐term and late‐term before delivery. The primary outcomes were neonatal birth weight and the risk of macrosomia.ResultsLate term triglyceride levels were positively associated with birth weight (β = 126.40, 95% CI: 61.95, 190.84, p < .001) and risk of macrosomia (OR = 2.11, 95% CI: 1.12, 3.98, p = .022). Late mid‐term triglyceride was positively associated with birth weight (β = 27.58, 95% CI: 9.67, 45.50, p = .003), and no correlation with risk of macrosomia (OR = 1.12, 95% CI: 0.95, 1.31, p = .178). Mid‐term triglyceride was not associated with birth weight (β = 45.79, 95% CI: −28.73, 120.30, p = .229) and risk of macrosomia (OR = 1.83, 95% CI: 0.89, 3.78, p = .101).ConclusionLate triglyceride levels were associated with birth weight and risk of macrosomia, while late to mid‐term triglyceride were associated with birth weight but not with risk of macrosomia. This suggests that maternal triglyceride changes may affect fetal growth and development, and more studies focusing on the effects of gestational triglyceride profiles are warranted.